Rhythm Pharmaceuticals buy UBS Group AG
Start price
17.12.25
/
50%
€95.50
Target price
17.12.26
-
Performance (%)
0.00%
Price
07:33
?
Summary
This prediction is currently active. UBS_Group_AG's BUY prediction for Rhythm Pharmaceuticals is currently unchanged. This prediction currently runs until 17.12.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | 0.00% |
| iShares Core DAX® | -1.212% |
| iShares Nasdaq 100 | -4.714% |
| iShares Nikkei 225® | -2.976% |
| iShares S&P 500 | -2.744% |
Comments by UBS_Group_AG for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for RYTM provided by MarketBeat